Nina D. Hobi, Dr. (he/him/his)

AlveoliX AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland

Nina Hobi`s career covers academic and industrial research, lecturing, and biotech development and scale-up. She has more than 12 years’ experience in respiratory research, human cell biology and physiology, and the development of healthy and diseased in-vitro models. Completing her Ph.D. in respiratory physiology and cell biology at the University of Innsbruck, she continued as a postdoctoral researcher and lung research group leader at the Universities of Ulm and Bern. Today, Nina Hobi is Co-CEO and Scientific Director of AlveoliX, a young Swiss biotech company with the head-quarter in Bern and the fabrication site in Biel. AlveoliX is providing innovative in-vitro solutions by combining unique microfluidic technology with state-of-the-art organ-on-chip bio-modelling. As part of the AlveoliX research team, Nina Hobi is dedicated to making organs-on-chip technology the new standard for preclinical decision-making and bringing data from bench to clinic.

Disclosure information not submitted.

Presentation(s):

• A novel gut-on-chip model recreating physiological 3D peristalsis for disease modelling and efficacy testing

  Monday, February 5, 2024
  4:00 PM – 4:30 PM EST